Shoulder Arthroplasty Market

Market Overview:

The global shoulder arthroplasty market size reached US$ 1.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2028, exhibiting a growth rate (CAGR) of 6% during 2023-2028.

Shoulder arthroplasty is a surgical procedure wherein diseases or damaged ball and socket joints of the shoulder are replaced with a prosthesis made of metal components or plastic implants. It is generally performed after a thorough evaluation of patients using x-rays, blood tests, bone scans, physical examinations, computed tomography (CT) scans, and magnetic resonance imaging (MRI) scans. Presently, it is used to treat individuals with primary osteoarthritis, post-traumatic arthritis, inflammatory arthritis, proximal humeral fractures, osteonecrosis of the humeral head and neck, and pseudo paresis caused by rotator cuff deficiency.

Shoulder Arthroplasty Market Trends:

Several conditions, such as inflammatory arthritis, osteonecrosis involving the glenoid and post-traumatic degenerative joint disease, can cause shoulder pain and disability and interfere with the everyday activities of patients. Thus, a significant rise in the number of individuals suffering from these conditions represents one of the key factors augmenting the need for shoulder arthroplasty. Moreover, as shoulder pain increases with age, the growing aging population is catalyzing the adoption of shoulder arthroplasty to preserve their shoulder joint mobility and function. Apart from this, high-force and repetition activities required by athletics during performance can result in severe shoulder fracture or damage. This, in confluence with the increasing participation of individuals in professional sports, is influencing the market positively. Furthermore, market players are offering an extensive array of implants for shoulder reconstruction in different conditions. They are also introducing modern implants with a wide range of options, including resurfacing the humeral head, anatomic hemiarthroplasty, total shoulder arthroplasty, reverse shoulder arthroplasty, and trauma-specific implants for fractures and nonunions. This is anticipated to expand their overall share and drive the market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global shoulder arthroplasty market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on device, procedure, indication and end user.

Breakup by Device:

• Shoulder Arthroplasty Resurfacing Implants
• Shoulder Arthroplasty Trauma Devices
• Shoulder Arthroplasty Platform Systems
   

Breakup by Procedure:

• Partial Shoulder Arthroplasty
• Total Shoulder Arthroplasty
• Revision Shoulder Arthroplasty
   

Breakup by Indication:

• Arthritis
• Fracture/Dislocation
• Rotator Cuff Tear Arthropathy
• Hill Sachs Defect
• Others
   

Breakup by End User:

• Hospitals
• Orthopedic Centers
• Ambulatory Surgical Centers
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc., BioTek Instruments Inc. (Agilent Technologies Inc.), Conmed Corporation, DJO Global (Colfax Corporation), Exactech Inc., Implantcast GmbH, Integra LifeSciences Corporation, Johnson & Johnson, Kinamed Incorporated, Limacorporate S.p.A., Medacta Group, Smith and Nephew Plc, Stryker Corporation and Zimmer Biomet.

Report Coverage: